Brain natriuretic peptides in atherosclerotic renal artery stenosis and effects of renal angioplasty.

作者: Elzbieta Nowakowska-Fortuna , Aso Saeed , Gregor Guron , Michael Fu , Ola Hammarsten

DOI: 10.1159/000355746

关键词:

摘要: Background: We hypothesized that plasma levels of brain natriuretic peptide (BNP) and N-terminal pro-BNP (NT-proBNP) would be elevated, adiponectin concentrations reduced, in patients with atherosclerotic renal artery stenosis (ARAS) BNPs might used to identify who benefit from percutaneous transluminal angioplasty (PTRA). Methods: Data were collected before angiography 91 hypertension suspected ARAS (significant ARAS; n=47, non-RAS; n=44) 20 healthy controls (C). In analyses repeated four weeks after PTRA. Results: Ambulatory systolic blood pressure (ASBP) was significantly elevated the group vs. both C non-RAS groups. Baseline BNP NT-proBNP but not group. One month PTRA, ASBP reduced baseline (149±16 139±15 mm pConclusions: Patients showed concentrations, adiponectin, compared hypertensive individuals without RAS. Our data do no support use identification will have a beneficial response

参考文章(21)
M Mukoyama, K Nakao, K Hosoda, S Suga, Y Saito, Y Ogawa, G Shirakami, M Jougasaki, K Obata, H Yasue, Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. Journal of Clinical Investigation. ,vol. 87, pp. 1402- 1412 ,(1991) , 10.1172/JCI115146
Alaa Alhadad, Gregor Guron, Ella Fortuna-Nowakowska, Aso Saeed, Ingrid Mattiasson, Gert Jensen, Bengt Lindblad, Anders Gotts??ter, Hans Herlitz, Renal angioplasty causes a rapid transient increase in inflammatory biomarkers, but reduced levels of interleukin-6 and endothelin-1 1 month after intervention Journal of Hypertension. ,vol. 25, pp. 1907- 1914 ,(2007) , 10.1097/HJH.0B013E328244E2CA
Jose A. Silva, Albert W. Chan, Christopher J. White, Tyrone J. Collins, J. Stephen Jenkins, John P. Reilly, Stephen R. Ramee, Elevated Brain Natriuretic Peptide Predicts Blood Pressure Response After Stent Revascularization in Patients With Renal Artery Stenosis Circulation. ,vol. 111, pp. 328- 333 ,(2005) , 10.1161/01.CIR.0000153271.77341.9F
Elzbieta Nowakowska Fortuna, Hans Herlitz, Aso Saeed, Per-Ola Attman, Gert Jensen, Petar Alaupovic, Gregor Guron, Lipoprotein abnormalities in patients with atherosclerotic renovascular disease. Kidney & Blood Pressure Research. ,vol. 34, pp. 311- 319 ,(2011) , 10.1159/000325648
Kazuhisa Maeda, Kousaku Okubo, Iichiro Shimomura, Tohru Funahashi, Yuji Matsuzawa, Kenichi Matsubara, cDNA Cloning and Expression of a Novel Adipose Specific Collagen-like Factor, apM1 (AdiposeMost Abundant Gene Transcript 1) Biochemical and Biophysical Research Communications. ,vol. 221, pp. 286- 289 ,(1996) , 10.1006/BBRC.1996.0587
Susan Vickery, Christopher P. Price, R. Ian John, Nasir A. Abbas, Michelle C. Webb, Michelle E. Kempson, Edmund J. Lamb, B-Type Natriuretic Peptide (BNP) and Amino-Terminal proBNP in Patients With CKD: Relationship to Renal Function and Left Ventricular Hypertrophy American Journal of Kidney Diseases. ,vol. 46, pp. 610- 620 ,(2005) , 10.1053/J.AJKD.2005.06.017
D. Staub, T. Zeller, D. Trenk, C. Maushart, H. Uthoff, T. Breidthardt, T. Klima, M. Aschwanden, T. Socrates, N. Arenja, R. Twerenbold, A. Rastan, S. Sixt, A.L. Jacob, K.A. Jaeger, C. Mueller, Use of B-Type Natriuretic Peptide to Predict Blood Pressure Improvement after Percutaneous Revascularisation for Renal Artery Stenosis European Journal of Vascular and Endovascular Surgery. ,vol. 40, pp. 599- 607 ,(2010) , 10.1016/J.EJVS.2010.07.013